• 1
    Pisani P, Ferlay J: Prevalence data, in FerlayJ, BlackRJ, PisaniP, et al (eds): EUCAN90: Cancer in the European Union. Lyon, France, International Agency for Research on Cancer, 1996, pp 56. IARC CancerBase No. 1.
  • 2
    Pisani P, Parkin DM, Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985: Implications for prevention, and projections of future burden. Int J Cancer 1993; 55: 891903.
  • 3
    Parkin DM, Hakulinen T: Analysis of survival, in JensenOM, ParkinDM, MaclennanR, et al (eds): Cancer Registration, Principles and Methods. Lyon, France, International Agency for Research on Cancer, 1991, pp 159176. IARC Scientific Publication No. 95
  • 4
    Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of twenty-five major cancers in 1990. Int J Cancer 1998, in press.
  • 5
    Ferlay J, Parkin DM, Pisani P: GLOBOCAN: Cancer Incidence and Mortality Worldwide. Lyon, France, International Agency for Research on Cancer, 1998. IARC CancerBase No. 3.
  • 6
    World Health Statistics Annual. Geneva, Switzerland, World Health Organization, 1993.
  • 7
    SankaranarayananR, BlackRJ, ParkinDM (eds): Cancer Survival in Developing Countries. Lyon, France, International Agency for Research on Cancer, 1998, in press. IARC Scientific Publication No. 145.
  • 8
    Gloeckler-RiesLA, KosaryCL, HankeyBF, et al (eds): SEER Cancer Statistics Review 1973–1994. Bethesda, MD, US Dept of Health and Human Services, National Cancer Institute, 1997. NIH Publication No. 97–2789.
  • 9
    BerrinoF, SantM, VerdecchiaA, et al (eds): Survival of Cancer Patients in Europe: The EURO-CARE Study. Lyon, France, International Agency for Research on Cancer, 1995. IARC Scientific Publication No. 132.
  • 10
    Doll R, Peto R: The Causes of Cancer. Oxford, Oxford University Press, 1981.
  • 11
    Parkin DM, Pisani P, Lopez AD, et al: At least one in seven cases of cancer is caused by smoking: Global estimates for 1985. Int J Cancer 1994; 59: 494504.
  • 12
    IARC Monograph on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France, International Agency for Research on Cancer, 1994.
  • 13
    Eurogast Study Group: An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 13591362.
  • 14
    Parkin DM, Pisani P, Muñoz N, et al: The global health burden of infection associated cancers. Cancer Surv, 1998, in press.
  • 15
    Banatvala N, Mayo K, Megraud F, et al: The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168, 219221.
  • 16
    Ziegler RG, Hoover RN, Pike MC, et al: Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 18191827.
  • 17
    Kelsey JL, Gammon MD: Epidemiology of breast cancer. Epidemiol Rev 1990; 12: 228240.
  • 18
    Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 4368.
  • 19
    McMichael AJ, McCall MG, Hartshorne JM, et al: Patterns of gastro-intestinal cancer in European migrants to Australia: The role of dietary change. Int J Cancer 1980; 25: 431437.
  • 20
    Donato F, Boffetta P, Puoti MA: A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998; 75: 347354.
  • 21
    Tanaka H, Hiyama T, Tsukuma H, et al: Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994; 5: 409413.
  • 22
    Chang MH, Chen CJ, Lai MS, et al: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 18551859.
  • 23
    Saxen EA: Trends: Facts or fallacy? in MagnusK (ed): Trends in Cancer Incidence: Causes and Practical Implications. Washington DC, Hemisphere, 1982, pp 516.
  • 24
    Shimizu H, Ross RK, Bernstein L: Possible underestimation of the incidence rate of prostate cancer in Japan. Jpn J Cancer Res 1991; 82: 483485.
  • 25
    Yatani R, Chigusa I, Akazaki K, et al: Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982; 29: 611616.
  • 26
    Shibata A, Whittemore A: Genetic predisposition to prostate cancer: Possible explanations for ethnic differences in risk. Prostate 1997; 32: 6572.
  • 27
    Brawley OW: Prostate carcinoma incidence and patient mortality: The effects of screening and early detection. Cancer 1997; 80: 18571863.
  • 28
    Threlfall TJ, English DR, Rouse IL: Prostate cancer in Western Australia: Trends in incidence and mortality from 1985 to 1996. Med J Aust 1998; 169: 2124.
  • 29
    IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 64. Human Papillomavirus. Lyon, France, International Agency for Research on Cancer, 1995.
  • 30
    Munoz N, Day N: Esophageal cancer, in SchottenfeldD, FraumeniJF (eds): Cancer Epidemiology and Prevention, ed 2. New York, Oxford University Press, 1996.
  • 31
    Hankey BF, Edwards BK, Ries LA, et al: Problems in cancer surveillance: Delineating in situ and invasive bladder cancer. J Natl Cancer Inst 1991; 83: 384385. Editorial.
  • 32
    ParkinDM, WhelanSL, FerlayJ, et al (eds): Cancer Incidence in Five Continents. Vol VII. Lyon, France, International Agency for Research on Cancer, 1997, pp 10281029. IARC Scientific Publication No. 143.